We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+13.06%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$4.23B
AUM Growth
+$208M
Cap. Flow
+$22.5M
Cap. Flow %
0.53%
Top 10 Hldgs %
66.8%
Holding
503
New
83
Increased
81
Reduced
97
Closed
181
Avg Time Held Equity + Options
4.4 quarters
Top 10 Avg Time Held Equity + Options
1.5 quarters
Top 20 Avg Time Held Equity + Options
1.6 quarters
Avg Time Held Equity only
4.5 quarters
Top 10 Avg Time Held Equity only
1.5 quarters
Top 20 Avg Time Held Equity only
1.6 quarters

Sector Composition

Rank Sector Weight
1 Energy 17.21%
2 Healthcare 16.93%
3 Financials 12.93%
4 Industrials 12.5%
5 Technology 10.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
ALV icon
326
Autoliv
ALV
$8.01B
– –
-162,490
Closed -$15.2M –
AM icon
327
PUT
Antero Midstream
AM
$10B
– –
-95,800
Closed -$2.4K –
ANET icon
328
Arista Networks
ANET
$266B
– –
-30,000
Closed -$3.32M –
ARCB icon
329
ArcBest
ARCB
$2.9B
– –
-40,130
Closed -$3.74M –
ARDX icon
330
CALL
Ardelyx
ARDX
$837M
– –
-120,000
Closed -$3K –
ARDX icon
331
Ardelyx
ARDX
$837M
– –
-49,701
Closed -$252K –
ARGX icon
332
argenx
ARGX
$51.5B
– –
-610
Closed -$375K –
ARKO icon
333
CALL
ARKO Corp
ARKO
$468M
– –
-80,000
Closed -$12K –
ARVN icon
334
CALL
Arvinas
ARVN
$494M
– –
-40,000
Closed -$15K –
ASAN icon
335
Asana
ASAN
$2.3B
– –
-25,000
Closed -$507K –
ATXS icon
336
DELISTED
Astria Therapeutics
ATXS
– –
-129,666
Closed -$1.16M –
BALY icon
337
Bally's
BALY
$699M
– –
-1,349,803
Closed -$24.1M –
BAX icon
338
CALL
Baxter International
BAX
$12.8B
– –
-50,000
Closed -$23.8K –
BDTX icon
339
Black Diamond Therapeutics
BDTX
$103M
– –
-104,560
Closed -$224K –
BE icon
340
PUT
Bloom Energy
BE
$76.7B
– –
-35,000
Closed -$5.25K –
BEAM icon
341
CALL
Beam Therapeutics
BEAM
$2.63B
– –
-20,000
Closed -$11K –
BIDU icon
342
Baidu
BIDU
$28.7B
– –
-43,756
Closed -$3.69M –
BILI icon
343
Bilibili
BILI
$6.23B
– –
-231,163
Closed -$4.19M –
BKR icon
344
Baker Hughes
BKR
$55.7B
– –
-145,990
Closed -$5.99M –
BLCO icon
345
Bausch + Lomb
BLCO
$5.67B
– –
-52,460
Closed -$947K –
BOX icon
346
Box
BOX
$5.05B
– –
-32,500
Closed -$1.03M –
BSX icon
347
Boston Scientific
BSX
$63B
– –
-8,334
Closed -$744K –
CAPR icon
348
CALL
Capricor Therapeutics
CAPR
$438M
– –
-30,000
Closed -$54K –
CAPR icon
349
Capricor Therapeutics
CAPR
$438M
– –
-104,798
Closed -$1.45M –
CARR icon
350
Carrier Global
CARR
$45.8B
– –
-187,000
Closed -$12.8M –

Similar funds

UBS O'Connor's Q1 2025 Portfolio in Review

As of Q1 2025, UBS O'Connor held 503 positions worth $4.23B, up 5.2% from $4.02B the previous quarter. Its ten largest holdings account for 67% of the portfolio.

UBS O'Connor's Q1 2025 filing shows 83 new, 81 increased, 97 reduced and 181 closed positions. Its largest new stake was Beacon Roofing Supply, Inc.: 1,575,016 shares worth $195M. The largest sale was HashiCorp, Inc. Class A Common Stock, an estimated $235M.

By sector, the portfolio is most concentrated in Energy at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.

  • UBS O'Connor's largest Q1 2025 buy was Beacon Roofing Supply, Inc.: 1,575,016 shares worth $195M.
  • UBS O'Connor added most to Intra-Cellular Therapies Inc. in Q1 2025, an estimated $383M increase.
  • UBS O'Connor's biggest Q1 2025 reduction was Juniper Networks, cutting an estimated $71.4M.
  • UBS O'Connor fully exited HashiCorp, Inc. Class A Common Stock in Q1 2025, selling an estimated $235M.
  • UBS O'Connor's ten largest holdings make up 67% of its $4.23B portfolio in Q1 2025.
  • UBS O'Connor opened 83 new positions and closed 181 in Q1 2025.
  • UBS O'Connor's portfolio value rose 5.2% quarter-over-quarter to $4.23B.

Based on UBS O'Connor's 13F filing for Q1 2025, filed 15 May 2025.